At TREAT-NMD, we are passionate about advancing the diagnosis, care and treatment for those living with neuromuscular disease and couldn’t be happier to hear about this new partnership between CureDuchenne and Blizzard Entertainment. The partnership aims to support the fight against Duchenne muscular dystrophy (DMD) through a unique in-game promotion in the popular game World of Warcraft®, helping to raise vital funds and awareness for DMD.
Duchenne
Early Diagnosis of Duchenne Muscular Dystrophy: Insights from TREAT-NMD’s International Workshop
A new report on the early diagnosis of Duchenne muscular dystrophy (DMD) has been published in the Journal of Neuromuscular Disorders. This report summarises the findings from TREAT-NMD’s 2023 international workshop, which brought together 42 experts from Europe, the US, and Australasia, including healthcare professionals, researchers, and individuals with lived experience.
World Duchenne Awareness Day 2024: Raising Our Voices for Duchenne
This Saturday, September 7th, marks World Duchenne Awareness Day (WDAD), an important occasion to raise awareness for Duchenne. Around the globe, communities come together to shine a light on these conditions, highlighting the need for greater support, research, and care.
Therapeutic Grant Call: Developing Transformative DMD Therapies
Therapeutic grant call for developing transformative DMD therapies. – submissions accepted until 4th August 2024.
Applications For the Duchenne Parent Project Netherlands’ 2024 Research Grant Are Now Open!
The 2024 research grant presents an opportunity to shape the future landscape of Duchenne research. By funding innovative projects and fostering collaboration, Duchenne Parent Project Netherlands aims to accelerate progress towards effective treatments and therapies for Duchenne muscular dystrophy.
TREAT-NMD Unveils Groundbreaking Programme to Revolutionise Rare Disease Treatment
TREAT-NMD are proud to announce the launch of the PaLaDIn project, an incredibly exciting and ambitious new project that aims to accelerate research, understanding and treatment for neuromuscular and other rare diseases.
